Copertina

Paramagnetic Rim Lesions in Highly Active Multiple Sclerosis at the Time of Disease Diagnosis: Prevalence Data and Clinical Implications

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Alessandra Cicia, Matteo Lucchini, Gianluca Di Fiore, Luca Ausili Cefaro, Assunta Bianco, Viviana Nociti, Vincenzo Carlomagno, Simona Gaudino, Massimiliano Mirabella
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	European Journal of Neurology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis
di: Kimberly H. Markowitz, et al.
Pubblicazione: (2026)

Paramagnetic Rim Lesions Are Associated With Trans‐Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis
di: Abdul Jaber Tayem, et al.
Pubblicazione: (2026)

Topographical Variation of Iron‐Rimmed Lesions in the Multiple Sclerosis Brain and Spinal Cord: A Neuropathological Study
di: Marco Pisa, et al.
Pubblicazione: (2026)

Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis
di: Monica Margoni, et al.
Pubblicazione: (2024)

Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy
di: Vincenzo Pota, et al.
Pubblicazione: (2024)

Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions
di: Antonio Scalfari, et al.
Pubblicazione: (2024)

Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis
di: Federico Ranieri, et al.
Pubblicazione: (2025)

RNA Binding Protein Dysfunction Links Smoldering/Slowly Expanding Lesions to Neurodegeneration in Multiple Sclerosis
di: Miranda L. Messmer, et al.
Pubblicazione: (2024)

Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis
di: Anthony Chomyk, et al.
Pubblicazione: (2024)

Detecting New Lesions Using a Large Language Model: Applications in Real‐World Multiple Sclerosis Datasets
di: Shane Poole, et al.
Pubblicazione: (2025)

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
di: Massimiliano Calabrese, et al.
Pubblicazione: (2024)

Lesion Location and Functional Connections Reveal Cognitive Impairment Networks in Multiple Sclerosis
di: Alessandro Franceschini, et al.
Pubblicazione: (2025)

Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease
di: Rosario Vasta, et al.
Pubblicazione: (2025)

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis
di: Fortunata Carbone, et al.
Pubblicazione: (2025)

Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody‐associated Disease, Aquaporin‐4 Antibody‐Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
di: Rosa Cortese, et al.
Pubblicazione: (2024)

Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics
di: Gianmarco Abbadessa, et al.
Pubblicazione: (2025)

High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Study
di: Richard Nicholas, et al.
Pubblicazione: (2024)

The Epidemiology of Primary Lateral Sclerosis: Results from a Population‐Based Cohort
di: Rosario Vasta, et al.
Pubblicazione: (2025)

Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study
di: Viviana Nociti, et al.
Pubblicazione: (2024)

Predicting Epileptogenic Tubers in Patients With Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning
di: Tinghong Liu, et al.
Pubblicazione: (2025)

New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond
di: Gary Birnbaum
Pubblicazione: (2025)

Social Cognition in Multiple Sclerosis: A Multidomain Investigation
di: Dalya Eda Akbalık, et al.
Pubblicazione: (2026)

Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis
di: Rosario Vasta, et al.
Pubblicazione: (2025)

Generics, Biosimilars and Follow‐On Non‐Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists
di: Thomas Berger, et al.
Pubblicazione: (2025)

Jaw Clonus in Amyotrophic Lateral Sclerosis
di: Ryuichi Inoue, et al.
Pubblicazione: (2026)

Erythrocyte Fragility in Progressive Multiple Sclerosis
di: Carmen Jacob, et al.
Pubblicazione: (2026)

Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis
di: Wallace J. Brownlee, et al.
Pubblicazione: (2024)

Obesity and Multiple Sclerosis Severity: A Mendelian Randomization Study
di: Fatema Alzamanan, et al.
Pubblicazione: (2024)

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis
di: Ali Manouchehrinia, et al.
Pubblicazione: (2025)

Reply to “New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond”
di: Joseph J. Sabatino, et al.
Pubblicazione: (2025)

Hospital‐Treated Infections and Risk of Disability Worsening in Multiple Sclerosis
di: Yihan Hu, et al.
Pubblicazione: (2024)

Wine Glass Sign in Bulbar Onset Amyotrophic Lateral Sclerosis
di: Prashant Bhatele, et al.
Pubblicazione: (2024)

Letter on Wine Glass Sign in Bulbar‐Onset Amyotrophic Lateral Sclerosis
di: Yu Zhu, et al.
Pubblicazione: (2025)

Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients
di: Matthew R. Brier, et al.
Pubblicazione: (2024)

The Scientific and Therapeutic Rationale for Off‐Label Treatments in Amyotrophic Lateral Sclerosis
di: Richard Bedlack, et al.
Pubblicazione: (2024)

Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study
di: Dimitrios Papadopoulos, et al.
Pubblicazione: (2025)

Comprehensive Analysis of Sex Differences in Amyotrophic Lateral Sclerosis Prognosis and Disease Progression
di: Liangping Zhang, et al.
Pubblicazione: (2024)

Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials
di: Marta Mascareñas‐García, et al.
Pubblicazione: (2026)

Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study
di: Luyi Zhu, et al.
Pubblicazione: (2024)

Understanding Routine Treatment and Resource Availability for Fatigue in Multiple Sclerosis in the United Kingdom
di: Federica Picariello, et al.
Pubblicazione: (2026)